Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
Abstract Background Digoxin is a widely prescribed drug for congestive heart failure and atrial fibrillation. Digoxin has a narrow therapeutic index and toxicity can develop quite easily. Digoxin immune fab (DIF) is an effective treatment for toxicity, however there are limited studies characterizin...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Adis, Springer Healthcare
2024-06-01
|
| Sarja: | Drugs - Real World Outcomes |
| Linkit: | https://doi.org/10.1007/s40801-024-00435-0 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|